Pacira | PCRX - Current Liabilities

Stock Price
20.93
Daily Change
-0.29 -1.37%
Monthly
-16.61%
Yearly
-21.29%
Q1 Forecast
19.91

Pacira reported $107.08M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Astellas Pharma JPY 1.33T 217.52B Sep/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Ironwood Pharmaceuticals USD 242.5M 9.98M Sep/2025
J&J USD 50.87B 3.31B Sep/2025
Ligand Pharmaceuticals USD 30.54M 34.2M Sep/2025
Novo Nordisk DKK 234.36B 26.84B Sep/2025
Pacira USD 107.08M 206.09M Sep/2025
Perrigo USD 1.15B 19.2M Sep/2025
Pfizer USD 36.6B 1.13B Sep/2025
Supernus Pharmaceuticals USD 330.63M 44.27M Sep/2025
Teva Pharmaceutical Industries USD 13.46B 1.96B Dec/2025
Xeris Pharmaceuticals USD 116.2M 21.03M Sep/2025
Zoetis USD 1.81B 1.56B Sep/2025